Delivery Order SPE2DB20D1100-SPE2DB25FB8V4
- Not listed
- The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packaging, with a ceiling value of $1,559.56. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,492.00 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewables under contract 4568864711. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,326.13 delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units, with a ceiling value of $8,195.85. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $7,266.59. This competitively awarded, firm fixed-price delivery order is set to conclude by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition based on...
- The Defense Logistics Agency awarded a delivery order valued at $18,131.18 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,232.22 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of supply on August 19, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,317.21 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under delivery order contract 4569293882. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB8V4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $3,152.63. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by April 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying medications and medical supplies to military and veteran healthcare systems. The parent IDC enables AmerisourceBergen to deliver a broad range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The current delivery order for Emverm represents a routine pharmaceutical supply transaction within the company's extensive federal medical procurement portfolio, which demonstrates its established capability to fulfill federal contracting requirements through competitive processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/22/25 |